AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer
Public ClinicalTrials.gov record NCT00493441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study was designed to find the optimum AVN944 dose to use in combination with gemcitabine in patients with pancreatic cancer and see if the combination of the 2 drugs was more effective for treating pancreatic cancer than using gemcitabine alone.
Study identification
- NCT ID
- NCT00493441
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 28 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2007 (Type not available)
- Primary completion
- Dec 2009 (Actual)
- Completion
- Dec 2009 (Actual)
- Last update posted
- Sep 30, 2020
2007 – 2009
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Clinical Research Center | Tucson | Arizona | 85715 | — |
| University of Southern California - Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| California Pacific Medical Center Research Institute | San Francisco | California | 94115 | — |
| Yale University | New Haven | Connecticut | 06520 | — |
| Georgetown University, Lombardi Comprehensive Cancer Center | Washington D.C. | District of Columbia | 20007 | — |
| University of Florida - Shands Cancer Center | Gainesville | Florida | 32610 | — |
| Emory University - Winship Cancer Institute | Atlanta | Georgia | 30322 | — |
| Joliet Oncology and Hematology Associates | Joliet | Illinois | 60435 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Columbia University | New York | New York | 10032 | — |
| Hematology Oncology Associates of Rockland | Nyack | New York | 10960 | — |
| Cleveland Clinic - Taussig Cancer Center | Cleveland | Ohio | 44195 | — |
| Chattanooga Oncology and Hematology Associates | Chattanooga | Tennessee | 37404 | — |
| University of Tennessee Medical Center | Knoxville | Tennessee | 37920 | — |
| Sarah Cannon Research Institute -Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| Virginia Cancer institute | Richmond | Virginia | 23230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00493441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2020 · Synced Oct 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00493441 live on ClinicalTrials.gov.